Aug 7 (Reuters) - CorMedix Inc ( CRMD ):
* CORMEDIX TO ACQUIRE MELINTA THERAPEUTICS, CREATING
DIVERSIFIED
SPECIALTY COMPANY WITH STRONG PRESENCE IN ACUTE CARE SETTINGS
* CORMEDIX TO ACQUIRE MELINTA THERAPEUTICS, CREATING
DIVERSIFIED
SPECIALTY COMPANY WITH STRONG PRESENCE IN ACUTE CARE SETTINGS
* CORMEDIX INC ( CRMD ) - SELLING SHAREHOLDERS TO RECEIVE $300
MILLION
INCLUDING $40 MILLION EQUITY
* CORMEDIX INC ( CRMD ) - DEAL EXPECTED TO BE NEAR-TERM ACCRETIVE TO
EPS
WITH DOUBLE-DIGIT ACCRETION EXPECTED IN 2026
* CORMEDIX INC ( CRMD ): ANNUAL RUN-RATE SYNERGIES EXPECTED TO BE
ABOUT $35
TO $45 MILLION
* CORMEDIX INC ( CRMD ) - PRO FORMA 2025 COMBINED REVENUES ESTIMATED
AT
$305-$335 MILLION
* CORMEDIX INC ( CRMD ) - TO PAY $300 MILLION UPFRONT
Source text:
Further company coverage: